FDA Adverse Event Injury Summary report: N

GORE EXCLUDER AAA ENDOPROSTHESIS

MDR report key: 1972259 · Received January 20, 2011

Report

Report Number
2953161-2011-00016
Event Type
Injury
Date Received
January 20, 2011
Date of Event
March 10, 2010
Report Date
January 20, 2011
Manufacturer
W. L. GORE & ASSOCIATES, INC.
Product Code
MIH
PMA / PMN Number
P020004
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
AL, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

METHOD- A REVIEW OF THE MANUFACTURING PAPERWORK HAS BEEN CONDUCTED. RESULTS- THE REVIEW OF THE MANUFACTURING PAPERWORK VERIFIED THAT THIS LOT MET ALL PRE-RELEASE SPECIFICATIONS.

Description of Event or Problem · 1

ON (B)(6) 2009, THIS PATIENT UNDERWENT TREATMENT FOR AN ABDOMINAL AORTIC ANEURYSM AND LARGE LEFT AND RIGHT INTERNAL ILIAC ARTERY ANEURYSMS. A GORE EXCLUDER AAA ENDOPROSTHESIS TRUNK-IPSILATERAL LEG COMPONENT WAS IMPLANTED WITH A CONTRALATERAL LEG COMPONENT IMPLANTED FOR EXTENSION ON THE RIGHT. INTRA-OPERATIVE ANGIOGRAPHY REPORTEDLY IDENTIFIED A DISTAL TYPE I ENDOLEAK ON THE PATIENT'S RIGHT SIDE, SO AN ILIAC EXTENDER COMPONENT WAS IMPLANTED FOR DISTAL EXTENSION. FINAL ANGIOGRAPHY SHOWED NO EVIDENCE OF ENDOLEAK, AND THE PATIENT TOLERATED THE PROCEDURE. IT WAS REPORTED THAT A FOLLOW-UP COMPUTED TOMOGRAPHY (CT) SCAN TAKEN ON AN UNKNOWN DATE SHOWED A POSSIBLE DISTAL TYPE I ENDOLEAK FROM THE LEFT COMMON ILIAC ARTERY. ON (B)(6) 2010, THE PATIENT WAS BROUGHT TO THE CATHETER LAB FOR AN ANGIOGRAM. IT WAS REPORTED THAT A SMALL TYPE I ENDOLEAK WAS AGAIN SEEN ON ANGIOGRAPHY, SO THE PHYSICIAN ELECTED TO IMPLANT AN ADDITIONAL CONTRALATERAL LEG COMPONENT IN THE LEFT EXTERNAL ILIAC ARTERY. THE PATIENT TOLERATED THE PROCEDURE. ON AN UNKNOWN DATE, A FOLLOW-UP CT SHOWED RESOLUTION OF THE LEFT DISTAL TYPE I ENDOLEAK.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 GORE EXCLUDER AAA ENDOPROSTHESIS MIH / SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT MIH W. L. GORE & ASSOCIATES, INC. WLG325 06718541

Patients

Seq Age Sex Outcome Treatment
1 79 YR Hospitalization| R